'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” ...

Jim Cramer, host of Mad Money, recently shared his thoughts following his interview with President-elect Donald Trump on the floor of the New York Stock Exchange. One of the key takeaways for ...

We recently published a list of 10 Jim Cramer Stocks to Watch in 2025. In this article, we are going to take a look at where ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

We recently compiled a list of the Jim Cramer Discusses 17 Stocks And Blasts ... as he mentioned Morgan Stanley's Benjamin ...

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

CNBC's Jim Cramer listed ten stocks he thinks will do well in December. Cramer said winners from November usually continue to perform during the last month of the year. Companies on the list ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

Jim Cramer urged investors to consider NVIDIA Corp.'s recent stock decline as a buying opportunity, despite the company's ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...